ARCHIVES

Gene Therapy Shows Positive Results In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

May 31, 2013

NIH To Give 3 Percent Increase to Grants

March 20, 2009

Audit Finds NIH Conflict of Interest Reports Scattered, Inaccessible, And Incomplete.

January 25, 2008

AACR honors Emil Frei III for pioneering work in childhood leukemia.

April 2, 2004

Patients urge Medicare to allow an open formulary for cancer treatment.

October 15, 2004